Recommended Topic Related To:

Rituxan

"The U.S. Food and Drug Administration today approved Rituxan (rituximab) to treat certain patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow cancer.

Rituxan, an anti-cancer drug, is intended fo"...

Rituxan

OVERDOSE

There has been no experience with overdosage in human clinical trials. Single doses of up to 500 mg/m² have been administered in clinical trials.

CONTRAINDICATIONS

None.

Last reviewed on RxList: 10/21/2013
This monograph has been modified to include the generic and brand name in many instances.

A A A

Rituxan - User Reviews

Rituxan User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Rituxan sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.